Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-037184
Filing Date
2023-06-14
Accepted
2023-06-14 18:59:05
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3977
  Complete submission text file 0001209191-23-037184.txt   5370
Mailing Address C/O AVROBIO, INC. ONE KENDALL SQ, BLDG. 300, STE. 201 CAMBRIDGE MA 02139
Business Address
MACKAY GEOFFREY (Reporting) CIK: 0001741849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 231015568

Mailing Address 93 WORCESTER STREET WELLESLEY MA 02481
Business Address 570 PRESTON ST. SUITE 400 LOUISVILLE KY 40202 502-398-9250
Talaris Therapeutics, Inc. (Issuer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)